Heart Failure is a complex clinical syndrome resulting from structural or functional impairment of ventricular filling or ejection. This session provides an in-depth exploration of mechanisms, staging, diagnostic approaches, guideline-directed therapies, and emerging treatments. As its global burden rises, clinicians increasingly seek a focused heart conference to stay current with therapeutic advances.

The description covers HFrEF, HFpEF, HFmrEF, acute decompensated heart failure, right heart failure, cardiogenic shock, and advanced heart failure requiring device or transplant therapy. Participants will understand neurohormonal activation, remodeling, fibrosis, fluid overload, microvascular dysfunction, and metabolic derangements underlying disease progression.

A central component explores advanced heart failure management strategies, including the four pillars of therapy—ARNI, beta-blockers, MRAs, and SGLT2 inhibitors—plus diuretics, vasodilators, and comorbidity management. The session explains the role of CRT, ICD, LVAD, and pulmonary artery pressure monitoring devices.

Diagnostic tools include echo, CMR, natriuretic peptides, cardiopulmonary exercise testing, right heart catheterization, and wearable monitoring. Participants learn to manage exacerbations, optimize volume status, and tailor therapy in patients with CKD, diabetes, obesity, pulmonary hypertension, arrhythmias, or frailty.

Future therapies include targeted biologics, gene therapy, metabolic modulation, and telehealth-based remote management. By the end, participants will have a complete framework for managing heart failure across all disease stages.